Direct-to-Patient Clinical Supply Services: Amid the surge in remote clinical studies, the imperative of facilitating direct-to-patient distribution of clinical supplies has gained utmost importance for clinical sponsors. Renejix’s RxReach® Direct-to-Patient (DTP) services enable the seamless delivery of clinical supplies straight to patients’ homes, significantly reducing or even obviating the need for on-site clinical visits.
Similar Posts
Solutions for Drug Development
An array of advanced technologies at your disposal to address your molecule’s challenges and processing hurdles effectively, achieving the optimal dosage form.
Equipment Lists
Please check out the below links to access our list of equipments available at the respective locations1. Hauppauge, New York2. Islip, New…
Analytical Method Optimization Based on Quality by Design
Quality by Design (QbD) is a well-known pharmaceutical industry strategy for enhancing production processes, including active pharmaceutical ingredients and medicinal products. Companies…
FormaDose™ Design: Solution For Dosage Form Selection
FormaDose® Design Solution is a comprehensive drug design assessment consisting of a holistic review of the molecule, patient, and market considerations. Led…
Solid State Form Characterization for Drug Development
Characterizing an API’s different salt forms and polymorphs is an essential drug development task. The successful preclinical assessment and product development can…
Small Molecule Analytical Services
This document provides both a high-level overview of Renejix’s stand-alone small molecule analytical services, and a detailed list of services organized by…